Skip to main content
. Author manuscript; available in PMC: 2012 Sep 10.
Published in final edited form as: Ann Surg. 2010 Mar;251(3):470–476. doi: 10.1097/SLA.0b013e3181cf8a19

FIGURE 2.

FIGURE 2

Actuarial survival curves after resection of IPMN-associated invasive adenocarcinoma were significantly favorable compared with standard pancreatic adenocarcinoma. Survival analysis excluded 30 patients who died in the 30-day postoperative period (2.4%).